Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Other Operating Expenses (2011 - 2023)

Analysis

Cerenome (CNSY) Other Operating Expenses (2011 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 2.72 Mn
Mar 31, 2023 -2,000.00
Dec 31, 2021 -48,000.00
Sep 30, 2021 -18,000.00
Jun 30, 2020 781,000.00
Dec 31, 2019 -305,000.00
Sep 30, 2019 94,000.00
Jun 30, 2019 97,000.00
Mar 31, 2019 114,000.00
Dec 31, 2018 47,000.00
Sep 30, 2018 118,000.00
Jun 30, 2018 185,000.00
Mar 31, 2018 678,000.00
Dec 31, 2017 867,000.00
Sep 30, 2017 1.31 Mn
Jun 30, 2017 531,000.00
Mar 31, 2017 1.02 Mn
Dec 31, 2016 1.56 Mn
Sep 30, 2016 1.88 Mn
Jun 30, 2016 1.70 Mn